Allogeneic Stem Cell Therapy (Northwestern University)

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameAllogeneic Stem Cell Therapy (Northwestern University)

Drug Alias NameN/A

ClassificationCell and gene therapy > Cell therapy > Donor > AllogeneicCell and gene therapy > Cell therapy > Stem cell therapy > Hematopoietic stem cells therapy

Mechanisms of ActionCell replacements

TargetsNot applicable

Therapy Area/IndicationsCrohn Disease

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusDiscontinued (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesNorthwest University

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesNorthwestern University

Active IndicationsN/A

Inactive IndicationsCrohn Disease

Other Information

ATC CodeN/A